Know Cancer

forgot password

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer

Phase 3
Open (Enrolling)
Small Cell Lung Cancer

Thank you

Trial Information

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer

Subjects will receive standard of care treatment for SCLC with added treatment of Cisplatin
injection via endobronchial ultrasound aided bronchoscopy a total of four times. Outcome
measurements of tumor growth and survival will be compared to subjects receiving standard of
care treatment only.

Inclusion Criteria:

Competent adult English speaking subjects

- With limited stage SCLC who have completed standard of care treatment who are
responders with no evidence of disseminated disease other than CNS metastasis,

- With recurrent disseminated SCLC after standard of care treatment with symptoms
related to central tumor obstruction,

- With recurrent limited stage SCLC with mediastinal/hilar recurrence not previously
treated with intratumoral cisplatin

Exclusion Criteria:

- Subjects who do not meet the inclusion criteria

- Subjects who, in the opinion of the investigator, are at risk undergoing a

Type of Study:


Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Solid tumor growth after completion of interventional bronchoscopies

Outcome Description:

The Organization for Research and Treatment of Cancer Response Evaluation Criteria in Solid Tumors (RECIST) system will be used to grade the response to therapy.

Outcome Time Frame:

18 months

Safety Issue:


Principal Investigator

Michael A. Jantz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Florida


United States: Institutional Review Board

Study ID:




Start Date:

December 2011

Completion Date:

December 2016

Related Keywords:

  • Small Cell Lung Cancer
  • Lung Neoplasms
  • Small Cell Lung Carcinoma



University of Florida Gainesville, Florida  32610-0277